Particle.news

Download on the App Store

Connected Wearables Platform Advances Remote Sleep Apnea Monitoring

Apnimed's FDA-cleared ring pulse oximeter and pending software platform demonstrate high patient adherence and potential to transform sleep-related breathing care.

Image
Image
Image

Overview

  • The Connected Wearables platform integrates a ring pulse oximeter with a clinician dashboard to monitor sleep-related breathing disorders remotely.
  • Clinical trials have collected over 130,000 hours of sleep data since July 2024, with 18,116 nightly recordings across 100 clinical sites.
  • Trial results highlight an 85% patient adherence rate, with some patients voluntarily surpassing recommended usage periods.
  • The device is FDA-cleared for medical use, while the connected software awaits regulatory approval for broader deployment beyond clinical trials.
  • Researchers suggest multi-night data collection may provide more valuable insights than traditional single-night in-lab polysomnography.